call Toll Free (US/Canada): +1 866 658 6826 | call+1 425 320 4776 | call (UK): +44 1865 60 0662 | call (Ind): +91 9096278110 | email info(@)blueweaveconsulting.com
Home | About Us | Career | Services | Blog | Contact Us
Blueweave
Short Bowel Syndrome Market
Inquire Before Buying Request for Sample

Short Bowel Syndrome Market

Home Healthcare And Pharmaceutical Short Bowel Syndrome Market

Short Bowel Syndrome Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019–2029, Segmented By Type (GLP-2, Growth Hormone, Glutamine); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies); By Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)

  • Published Date: August 2023
  • Report ID: BWC23628
  • Available Format: PDF
  • Page: 400

Report Overview

Increasing prevalence of short bowel syndrome (SBS) and the growing demand for SBS drugs due to the high cost of parenteral nutrition are projected to propel the expansion of the global short bowel syndrome market during the forecast period between 2023 and 2029.

Global Short Bowel Syndrome Market - Industry Trends & Forecast Report, 2029

Global short bowel syndrome market size was estimated at USD 828.29 million in 2022. During the forecast period between 2023 and 2029, the size of global short bowel syndrome market is projected to grow at a CAGR of 14.05% reaching a value of USD 2,035.24 million by 2029. Major growth drivers for the global short bowel syndrome market include an increasing prevalence of gastrointestinal disorders, advancements in medical technology, and growing awareness among healthcare professionals and patients. The incidence of short bowel syndrome is rising globally, primarily due to factors such as gastrointestinal surgeries, congenital anomalies, inflammatory bowel diseases, and other conditions leading to the removal or dysfunction of a significant portion of the small intestine. This growing prevalence is driving the demand for effective treatment options. Advances in medical technology have significantly contributed to the development of novel therapies for short bowel syndrome. These include the development of parenteral nutrition solutions, intestinal transplantation procedures, and the use of intestinal rehabilitation programs. Technological advancements have improved patient outcomes and are expected to drive market growth. Also, pharmaceutical companies and research organizations are actively investing in research and development activities to discover and develop new treatment options for short bowel syndrome. These efforts aim to improve the quality of life for patients and address the unmet medical needs in this field. Hence, such aspects are expected to boost the expansion of the global short bowel syndrome market during the forecast period.

Short Bowel Syndrome Market

Global Short Bowel Syndrome Market – Overview

The global Short Bowel Syndrome (SBS) market encompasses the diagnosis, treatment, and management of a condition characterized by the loss or dysfunction of a significant portion of the small intestine. It involves pharmaceutical companies, medical device manufacturers, research organizations, and healthcare providers. Key products and services include pharmacological therapies, parenteral nutrition solutions, medical devices, surgical interventions, rehabilitation programs, and support services. The market is driven by factors such as the rising prevalence of gastrointestinal disorders, advancements in medical technology, research and development investments, and the need for effective SBS management. Market players strive to develop innovative therapies and interventions to improve patient outcomes and quality of life.

Global Short Bowel Syndrome Market

Growth Drivers

Increasing Prevalence of Short Bowel Syndrome

The global short bowel syndrome (SBS) market is experiencing significant growth, primarily driven by the increasing prevalence of this condition. SBS is becoming more common due to factors such as gastrointestinal surgeries, congenital anomalies, inflammatory bowel diseases, and other conditions that result in the removal or dysfunction of a significant portion of the small intestine. This rising prevalence creates a greater demand for effective treatment options, leading to the growth of the global Short Bowel Syndrome market. Pharmaceutical companies, medical device manufacturers, and research organizations are actively investing in research and development activities to discover new therapies and address the unmet medical needs in this field.

Restraints

High Cost of SBS Treatment

The high cost associated with Short Bowel Syndrome (SBS) treatment is a significant restraint on the growth of the global market. Managing SBS requires a combination of pharmacological therapies, parenteral nutrition solutions, medical devices, and potentially surgical interventions, all of which can be expensive. The cost of these treatments, including medications, specialized nutrition support, and medical devices, can pose a financial burden on patients and healthcare systems. The high cost of SBS treatment limits access to care and hinders market growth, particularly in regions with limited healthcare resources or where reimbursement coverage is insufficient. Finding cost-effective solutions and improving affordability are crucial for overcoming this challenge and promoting market expansion.

Impact of COVID-19 on Global Short Bowel Syndrome Market

COVID-19 pandemic adversely affected the global short bowel syndrome market. The healthcare systems' focus on managing COVID-19 cases, disruptions in the supply chain, and restrictions on non-essential healthcare services have affected the diagnosis, treatment, and management of SBS. Clinical trials for new therapies and medical device development have been delayed or halted, impacting research and development activities. Also, the economic impact of the pandemic has affected healthcare budgets, potentially limiting patients’ access to expensive SBS treatments. However, as the situation improved, the market gradually recovered, supported by increased healthcare investments and a resurgence in research and development efforts.

Global Short Bowel Syndrome Market

Segmental Coverage

Global Short Bowel Syndrome Market – By Type

By type, the global short bowel syndrome market is divided into GLP-2, Growth Hormone, and Glutamine segments. The GLP-2 (glucagon-like peptide-2) segment holds the highest share in the global Short Bowel Syndrome (SBS) market due to its effectiveness in managing the condition. GLP-2 is a hormone that plays a crucial role in promoting intestinal growth, enhancing nutrient absorption, and reducing fluid loss. It has shown promising results in clinical trials and is approved for the treatment of SBS in several regions. GLP-2 therapies, such as Teduglutide, have demonstrated the ability to reduce dependence on parenteral nutrition and improve intestinal function. The proven efficacy of GLP-2 treatments has led to their widespread adoption, contributing to the segment's dominant market share in the global SBS market.

Short Bowel Syndrome Market Size

Global Short Bowel Syndrome Market – By Distribution Channel

Based on distribution channel, the global short bowel syndrome market is bifurcated into Hospital Pharmacies and Retail Pharmacies segments. The retail pharmacies segment holds a higher market share by distribution channel due to their convenience and accessibility. With widespread distribution, they offer easy access to medications and supplies for SBS patients. Retail pharmacies have established networks, enabling efficient prescription fulfillment and insurance handling. Additional services like home delivery and medication synchronization enhance the patient experience and adherence. They play a vital role in raising awareness through community outreach and educational initiatives. Retail pharmacies' convenience, accessibility, established networks, and value-added services position them as the preferred channel for SBS patients, contributing to their high market share in the global market.

Short Bowel Syndrome Market Share

Global Short Bowel Syndrome Market – By Region

The in-depth research report on the global short bowel syndrome market covers various country-specific markets across five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America holds the highest market share and is projected to maintain its dominance over the forecast period. This is primarily due to the region's high prevalence of gastrointestinal disorders, including Short Bowel Syndrome (SBS). Additionally, North America benefits from advanced healthcare infrastructure, well-established regulatory frameworks, robust reimbursement systems, and a strong focus on research and development. Higher healthcare expenditure per capita and a well-developed network of specialty clinics and hospitals further contribute to North America's major market share. These factors collectively position the region as a leading market for SBS treatments and therapies.

Competitive Landscape

Major players operating in the global short bowel syndrome market include Takeda, Emmaus Life Sciences, Nutricia (Danone), Merck KGaA, GlyPharma Therapeutics, Zealand Pharma, Sancilio Pharmaceuticals, Naia Pharmaceuticals, Ardelyx, Adocia, Aralez Pharmaceuticals, Shield Therapeutics, OxThera, Rhythm Pharmaceuticals, and Pivot Pharmaceuticals. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

Recent Development

  • In October 2022 - VectivBio Holding AG announced the release of positive interim data from the company's Phase 2 study that evaluated the safety, pharmacokinetics, and efficacy of apraglutide, a GLP-2 agonist, in adult patients with Short Bowel Syndrome.

  • In June 2022 - 9 Meters Biopharma, Inc., a company headquartered in the United States, announced positive outcomes from a phase 2 clinical trial evaluating the effectiveness of Vurolenatide in the treatment of short bowel syndrome.

Scope of the Report

Attributes

Details

Years Considered

Historical Data – 2019–2022

Base Year – 2022

Estimated Year – 2023

Forecast Period– 2023–2029

Facts Covered

Revenue in USD Million

Market Coverage

North America, Europe, Asia Pacific, Latin America, Middle East and Africa

Product/ Service Segmentation

Type, Distribution Channel, Region

Key Players

Takeda, Emmaus Life Sciences, Nutricia (Danone), Merck KGaA, GlyPharma Therapeutics, Zealand Pharma, Sancilio Pharmaceuticals, Naia Pharmaceuticals, Ardelyx, Adocia, Aralez Pharmaceuticals, Shield Therapeutics, OxThera, Rhythm Pharmaceuticals, Pivot Pharmaceuticals.

 

By Type

  • GLP-2

  • Growth Hormone

  • Glutamine

By Distribution Channel

  • Hospital Pharmacies

  • Retail Pharmacies

By Region

  • North America

  • Europe

  • Asia Pacific (APAC)

  • Latin America (LATAM)

  • Middle East and Africa (MEA)

  1. Research Framework
    1. Research Objective
    2. Product Overview
    3. Market Segmentation
  2. Executive Summary
  3. Global Short Bowel Syndrome Market Insights
    1. Industry Value Chain Analysis
    2. DROC Analysis
      1. Growth Drivers
        1. Increasing prevalence of short bowel syndrome
        2. Growing demand for SBS drugs due to the high cost of parenteral nutrition
      2. Restraints
        1. High cost of SBS treatment
        2. Long-term complications of SBS
      3. Opportunities
        1. Development of new SBS drugs and therapies
        2. Partnerships and collaborations with other companies
      4. Challenges
        1. Stringent regulatory requirements
        2. Competition from generic drugs
    3. Technology Advancements/Recent Developments
    4. Regulatory Framework
    5. Porter’s Five Forces Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of New Entrants
      4. Threat of Substitutes
      5. Intensity of Rivalry
  4. Global Short Bowel Syndrome Market Overview
    1. Market Size & Forecast, 2019–2029
      1. By Value (USD Million)
    2. Market Share and Forecast
      1. By Type
        1. GLP-2
        2. Growth Hormone
        3. Glutamine
        4. Others
      2. By Distribution Channel
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Others
      3. By Region
        1. North America
        2. Europe
        3. Asia Pacific (APAC)
        4. Latin America (LATAM)
        5. Middle East and Africa (MEA)
  5. North America Short Bowel Syndrome Market
    1. Market Size & Forecast, 2019–2029
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Type
      2. By Distribution Channel
      3. By Country
        1. United States
          1. By Type
          2. By Distribution Channel
        2. Canada
          1. By Type
          2. By Distribution Channel
  6. Europe Short Bowel Syndrome Market
    1. Market Size & Forecast, 2019–2029
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Type
      2. By Distribution Channel
      3. By Country
        1. Germany
          1. By Type
          2. By Distribution Channel
        2. United Kingdom
          1. By Type
          2. By Distribution Channel
        3. Italy
          1. By Type
          2. By Distribution Channel
        4. France
          1. By Type
          2. By Distribution Channel
        5. Spain
          1. By Type
          2. By Distribution Channel
        6. Belgium
          1. By Type
          2. By Distribution Channel
        7. Russia
          1. By Type
          2. By Distribution Channel
        8. Rest of Europe
          1. By Type
          2. By Distribution Channel
  7. Asia Pacific Short Bowel Syndrome Market
    1. Market Size & Forecast, 2019–2029
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Type
      2. By Distribution Channel
      3. By Country
        1. China
          1. By Type
          2. By Distribution Channel
        2. India
          1. By Type
          2. By Distribution Channel
        3. Japan
          1. By Type
          2. By Distribution Channel
        4. South Korea
          1. By Type
          2. By Distribution Channel
        5. Australia & New Zealand
          1. By Type
          2. By Distribution Channel
        6. Indonesia
          1. By Type
          2. By Distribution Channel
        7. Malaysia
          1. By Type
          2. By Distribution Channel
        8. Singapore
          1. By Type
          2. By Distribution Channel
        9. Vietnam
          1. By Type
          2. By Distribution Channel
        10. Rest of APAC
          1. By Type
          2. By Distribution Channel
  8. Latin America Short Bowel Syndrome Market
    1. Market Size & Forecast, 2019–2029
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Type
      2. By Distribution Channel
      3. By Country
        1. Brazil
          1. By Type
          2. By Distribution Channel
        2. Mexico
          1. By Type
          2. By Distribution Channel
        3. Argentina
          1. By Type
          2. By Distribution Channel
        4. Peru
          1. By Type
          2. By Distribution Channel
        5. Rest of LATAM
          1. By Type
          2. By Distribution Channel
  9. Middle East & Africa Short Bowel Syndrome Market
    1. Market Size & Forecast, 2019–2029
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Type
      2. By Distribution Channel
      3. By Country
        1. Saudi Arabia
          1. By Type
          2. By Distribution Channel
        2. UAE
          1. By Type
          2. By Distribution Channel
        3. Qatar
          1. By Type
          2. By Distribution Channel
        4. Kuwait
          1. By Type
          2. By Distribution Channel
        5. South Africa
          1. By Type
          2. By Distribution Channel
        6. Nigeria
          1. By Type
          2. By Distribution Channel
        7. Algeria
          1. By Type
          2. By Distribution Channel
        8. Rest of MEA
          1. By Type
          2. By Distribution Channel
  10. Competitive Landscape
    1. List of Key Players and Their Offerings
    2. Global Short Bowel Syndrome Market Share Analysis, 2022
    3. Competitive Benchmarking, By Operating Parameters
    4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)
  11. Impact of Covid-19 on Global Short Bowel Syndrome Market
  12. Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)
    1. Takeda
    2. Emmaus Life Sciences
    3. Nutricia (Danone)
    4. Merck KGaA
    5. GlyPharma Therapeutics
    6. Zealand Pharma
    7. Sancilio Pharmaceuticals
    8. Naia Pharmaceuticals
    9. Ardelyx
    10. Adocia
    11. Aralez Pharmaceuticals
    12. Shield Therapeutics
    13. OxThera
    14. Rhythm Pharmaceuticals
    15. Pivot Pharmaceuticals
    16. Other Prominent Players
  13. Key Strategic Recommendations
  14. Research Methodology
    1.    Qualitative Research
      1.  Primary & Secondary Research
    2.    Quantitative Research
    3.    Market Breakdown & Data Triangulation
      1.  Secondary Research
      2.  Primary Research
    4.    Breakdown of Primary Research Respondents, By Region
    5.    Assumptions & Limitations

*Financial information of case of non-listed companies can be provided as per availability.

**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable

Figures

Figure 1       Global Short Bowel Syndrome Market Segmentation

Figure 2       Global Short Bowel Syndrome Market Value Chain Analysis

Figure 3       Company Market Share Analysis, 2022

Figure 4       Global Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029

Figure 5       Global Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029

Figure 6       Global Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029

Figure 7       Global Short Bowel Syndrome Market Share, By Region, By Value, 2019−2029

Figure 8       North America Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029

Figure 9       North America Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029

Figure 10     North America Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029

Figure 11     North America Short Bowel Syndrome Market Share, By Country, By Value, 2019−2029

Figure 12     United States Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029

Figure 13     United States Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029

Figure 14     United States Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029

Figure 15     Canada Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029

Figure 16     Canada Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029

Figure 17     Canada Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029

Figure 18     Europe Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029

Figure 19     Europe Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029

Figure 20     Europe Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029

Figure 21     Europe Short Bowel Syndrome Market Share, By Country, By Value, 2019−2029

Figure 22     Germany Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029

Figure 23     Germany Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029

Figure 24     Germany Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029

Figure 25     United Kingdom Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029

Figure 26     United Kingdom Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029

Figure 27     United Kingdom Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029

Figure 28     Italy Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029

Figure 29     Italy Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029

Figure 30     Italy Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029

Figure 31     France Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029

Figure 32     France Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029

Figure 33     France Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029

Figure 34     Spain Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029

Figure 35     Spain Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029

Figure 36     Spain Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029

Figure 37     Belgium Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029

Figure 38     Belgium Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029

Figure 39     Belgium Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029

Figure 40     Rest of Europe Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029

Figure 41     Rest of Europe Short Bowel Syndrome Market Share, By Technology, By Value, 2019−2029

Figure 42     Rest of Europe Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029

Figure 43     The Asia-Pacific Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029

Figure 44     The Asia-Pacific Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029

Figure 45     The Asia-Pacific Short Bowel Syndrome Market Share, By Deployment, By Value, 2019−2029

Figure 46     The Asia-Pacific Short Bowel Syndrome Market Share, By Country, By Value, 2019−2029

Figure 47     China Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029

Figure 48     China Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029

Figure 49     China Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029

Figure 50     India Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029

Figure 51     India Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029

Figure 52     India Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029

Figure 53     Japan Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029

Figure 54     Japan Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029

Figure 55     Japan Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029

Figure 56     South Korea Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029

Figure 57     South Korea Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029

Figure 58     South Korea Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029

Figure 59     Australia & New Zealand Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029

Figure 60     Australia & New Zealand Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029

Figure 61     Australia & New Zealand Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029

Figure 62     Indonesia Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029

Figure 63     Indonesia Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029

Figure 64     Indonesia Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029

Figure 65     Malaysia Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029

Figure 66     Malaysia Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029

Figure 67     Malaysia Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029

Figure 68     Singapore Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029

Figure 69     Singapore Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029

Figure 70     Singapore Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029

Figure 71     Vietnam Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029

Figure 72     Vietnam Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029

Figure 73     Vietnam Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029

Figure 74     Rest of Asia Pacific Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029

Figure 75     Rest of Asia Pacific Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029

Figure 76     Rest of Asia Pacific Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029

Figure 77     Latin America Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029

Figure 78     Latin America Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029

Figure 79     Latin America Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029

Figure 80     Latin America Short Bowel Syndrome Market Share, By Country, By Value, 2019−2029

Figure 81     Brazil Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029

Figure 82     Brazil Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029

Figure 83     Brazil Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029

Figure 84     Mexico Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029

Figure 85     Mexico Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029

Figure 86     Mexico Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029

Figure 87     Argentina Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029

Figure 88     Argentina Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029

Figure 89     Argentina Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029

Figure 90     Peru Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029

Figure 91     Peru Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029

Figure 92     Peru Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029

Figure 93     Rest of Latin America Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029

Figure 94     Rest of Latin America Short Bowel Syndrome Market Share, By Type By Value, 2019−2029

Figure 95     Rest of Latin America Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029

Figure 96     The Middle East & Africa Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029

Figure 97     The Middle East & Africa Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029

Figure 98     The Middle East & Africa Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029

Figure 99     The Middle East & Africa Short Bowel Syndrome Market Share, By Country, By Value, 2019−2029

Figure 100   Saudi Arabia Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029

Figure 101   Saudi Arabia Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029

Figure 102   Saudi Arabia Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029

Figure 103   UAE Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029

Figure 104   UAE Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029

Figure 105   UAE Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029

Figure 106   Qatar Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029

Figure 107   Qatar Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029

Figure 108   Qatar Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029

Figure 109   Kuwait Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029

Figure 110   Kuwait Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029

Figure 111   Kuwait Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029

Figure 112   Iran Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029

Figure 113   Iran Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029

Figure 114   Iran Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029

Figure 115   South Africa Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029

Figure 116   South Africa Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029

Figure 117   South Africa Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029

Figure 118   Nigeria Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029

Figure 119   Nigeria Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029

Figure 120   Nigeria Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029

Figure 121   Kenya Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029

Figure 122   Kenya Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029

Figure 123   Kenya Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029

Figure 124   Egypt Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029

Figure 125   Egypt Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029

Figure 126   Egypt Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029

Figure 127   Morocco Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029

Figure 128   Morocco Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029

Figure 129   Morocco Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029

Figure 130   Algeria Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029

Figure 131   Algeria Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029

Figure 132   Algeria Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029

Figure 133   Rest of Middle East & Africa Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029

Figure 134   Rest of Middle East & Africa Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029

Figure 135   Rest of Middle East & Africa Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029

                                                                  

Tables

Table 1 Global Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029

Table 2 Global Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029

Table 3 Global Short Bowel Syndrome Market Size, By Region, By Value, 2019−2029

Table 4 North America Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029

Table 5 North America Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029

Table 6 North America Short Bowel Syndrome Market Size, By Country, By Value, 2019−2029

Table 7 United States Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029

Table 8 United States Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029

Table 9 Canada Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029

Table 10      Canada Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029

Table 11      Europe Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029

Table 12      Europe Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029

Table 13      Europe Short Bowel Syndrome Market Size, By Country, By Value, 2019−2029

Table 14      Germany Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029

Table 15      Germany Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029

Table 16      United Kingdom Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029

Table 17      United Kingdom Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029

Table 18      Italy Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029

Table 19      Italy Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029

Table 20      France Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029

Table 21      France Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029

Table 22      Spain Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029

Table 23      Spain Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029

Table 24      Belgium Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029

Table 25      Belgium Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029

Table 26      Rest of Europe  Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029

Table 27      Rest of Europe Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029

Table 28      The Asia-Pacific Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029

Table 29      The Asia-Pacific Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029

Table 30      The Asia-Pacific Short Bowel Syndrome Market Size, By Country, By Value, 2019−2029

Table 31      China Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029

Table 32      China Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029

Table 33      India Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029

Table 34      India Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029

Table 35      Japan Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029

Table 36      Japan Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029

Table 37      South Korea Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029

Table 38      South Korea Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029

Table 39      Australia & New Zealand Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029

Table 40      Australia & New Zealand Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029

Table 41      Indonesia Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029

Table 42      Indonesia Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029

Table 43      Malaysia Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029

Table 44      Malaysia Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029

Table 45      Singapore Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029

Table 46      Singapore Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029

Table 47      Philippines Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029

Table 48      Philippines Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029

Table 49      Vietnam Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029

Table 50      Vietnam Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029

Table 51      Rest of Asia Pacific Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029

Table 52      Rest of Asia Pacific Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029

Table 53      Latin America Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029

Table 54      Latin America Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029

Table 55      Latin America Short Bowel Syndrome Market Size, By Country, By Value, 2019−2029

Table 56      Brazil Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029

Table 57      Brazil Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029

Table 58      Mexico Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029

Table 59      Mexico Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029

Table 60      Argentina Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029

Table 61      Argentina Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029

Table 62      Peru Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029

Table 63      Peru Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029

Table 64      Rest of Latin America Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029

Table 65      Rest of Latin America Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029

Table 66      The Middle East & Africa Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029

Table 67      The Middle East & Africa Short Bowel Syndrome Market Size, By Country, By Value, 2019−2029

Table 68      Saudi Arabia Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029

Table 69      Saudi Arabia Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029

Table 70      UAE Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029

Table 71      UAE Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029

Table 72      Qatar Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029

Table 73      Qatar Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029

Table 74      Kuwait Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029

Table 75      Kuwait Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029

Table 76      Iran Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029

Table 77      Iran Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029

Table 78      South Africa Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029

Table 79      South Africa Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029

Table 80      Nigeria Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029

Table 81      Nigeria Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029

Table 82      Kenya Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029

Table 83      Kenya Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029

Table 84      Egypt Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029

Table 85      Egypt Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029

Table 86      Morocco Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029

Table 87      Morocco Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029

Table 88      Algeria Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029

Table 89      Algeria Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029

Table 90      Rest of Middle East & Africa Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029

Table 91      Rest of Middle East & Africa Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029

Table 92      Takeda Company Overview

Table 93      Takeda Financial Overview

Table 94      Emmaus Life Sciences Company Overview

Table 95      Emmaus Life Sciences Financial Overview

Table 96      Nutricia (Danone) Company Overview

Table 97      Nutricia (Danone) Financial Overview

Table 98      Merck KGaA Company Overview

Table 99      Merck KGaA Financial Overview

Table 100    GlyPharma Therapeutics Company Overview

Table 101    GlyPharma Therapeutics Financial Overview

Table 102    Zealand Pharma Company Overview

Table 103    Zealand Pharma Financial Overview

Table 104    Sancilio Pharmaceuticals Company Overview

Table 105    Sancilio Pharmaceuticals Financial Overview

Table 106    Naia Pharmaceuticals Company Overview

Table 107    Naia Pharmaceuticals Financial Overview

Table 108    Ardelyx Company Overview

Table 109    Ardelyx Financial Overview

Table 110    Adocia Company Overview

Table 111    Adocia Financial Overview

Table 112    Aralez Pharmaceuticals Company Overview

Table 113    Aralez Pharmaceuticals Financial Overview

Table 114    Pivot Pharmaceuticals Company Overview

Table 115    Pivot Pharmaceuticals Financial Overview

Table 116    Other Prominent Players Company Overview

Table 117    Other Prominent Players Financial Overview

Market Segmentation

No data available
No data available

To request a free sample copy of this report, please complete the form below.

We value your investment and offer free customization with every report to fulfil your exact research needs.

Note: Please share the corporate email address for faster response

This website is secure and your personal details are safe.

Frequently Asked Questions (FAQs):

Ans: The GLP-2 segment is expected to hold the highest market share in the Global Short Bowel Syndrome Market by type.
Ans: Major factors driving the growth of the Global Short Bowel Syndrome Market include an increasing prevalence of short bowel syndrome and the growing demand for SBS drugs due to the high cost of parenteral nutrition.
Ans: Global Short Bowel Syndrome Market size was estimated at USD 828.29 million in 2022.
Ans: The retail pharmacies segment is expected to hold a higher market share in the Global Short Bowel Syndrome Market by distribution channel.
Ans: Key players in the Global Short Bowel Syndrome Market include Takeda, Emmaus Life Sciences, Nutricia (Danone), Merck KGaA, GlyPharma Therapeutics, Zealand Pharma, Sancilio Pharmaceuticals, Naia Pharmaceuticals, Ardelyx, Adocia, Aralez Pharmaceuticals, Shield Therapeutics, OxThera, Rhythm Pharmaceuticals, and Pivot Pharmaceuticals. 
array(1) {
  ["__ci_last_regenerate"]=>
  int(1732251456)
}